The initiative will operate for the next 12 months after receiving a 1 million SEK prize from Sweden's innovation agency, Vinnova
This personalized approach contrasts sharply with unsupervised or self-directed semaglutide use, where patients may increase their dose too quickly, accidentally double-dose, or ignore warning signs of dangerous complications
Alzheimer's Hallmarks: A and Phosphorylated Tau The neuropathology of AD is characterized by an abnormal build-up of extracellular amyloid- (A) peptide as neuritic plaques, pathological extracellular aggregates formed around a core of A and are a hallmark of AD (Stratmann et al., 2016), accompanied by intracellular hyperphosphorylated (p)-Tau fibrils which accumulate as neurofibrillary tangles (NFTs) within neurons (Stratmann et al., 2016)
By employing smaller doses, individuals can experience a gradual adaptation to the medication, which may lead to a reduction in adverse reactions and improved overall treatment tolerability